2306217-12-7: Varenicline N-oxide

Additional information on CAS 2306217-12-7

Catalogue No.

VE007007

CAS No.

2306217-12-7

Molecular Formula

C13H13N3O

Molecular Weight

227.27 g/mol

Parent drug

Varenicline

IUPAC Name

7, 8, 9, 10-tetrahydro-6H-6, 10-methanoazepino[4, 5-g]quinoxaline 1-oxide

Synonyms

N/A

References

Sci-Hub, Varenicline Is a Partial Agonist at 4beta2 and a Full Agonist at 7 Neuronal Nicotinic Receptors, 10.1124/mol.106.025130. (2022). Retrieved February 2, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1124/mol.106.025130

Status

In-stock

Request a quote

2306217-12-7: Varenicline N-oxide

2306217-12-7: Varenicline N-oxide
Catalogue No.

VE007007

CAS No.

2306217-12-7

Molecular Formula

C13H13N3O

Molecular Weight

227.27 g/mol

Parent drug

Varenicline

IUPAC Name

7, 8, 9, 10-tetrahydro-6H-6, 10-methanoazepino[4, 5-g]quinoxaline 1-oxide

Synonyms

N/A

References

Sci-Hub, Varenicline Is a Partial Agonist at 4beta2 and a Full Agonist at 7 Neuronal Nicotinic Receptors, 10.1124/mol.106.025130. (2022). Retrieved February 2, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1124/mol.106.025130

Status

In-stock

ListName

Varenicline N-oxide

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url